Erlotinib in lung cancer : Molecular and clinical predictors of outcomeTSAO, Ming-Sound; SAKURADA, Akira; MARRANO, Paula et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 133-144, issn 0028-4793, 12 p.Article

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer : NCIC IND-148OZA, Amit M; EISENHAUER, Elizabeth A; PROVENCHER, Diane et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4319-4325, issn 0732-183X, 7 p.Article

Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non―Small-Cell Lung CancerDJALALOV, Sandjar; BECA, Jaclyn; HOCH, Jeffrey S et al.Journal of clinical oncology. 2014, Vol 32, Num 10, pp 1012-1019, issn 0732-183X, 8 p.Article

Sulfasalazine -induced cystine starvation : Potential use for prostate cancertherapyDOXSEE, Daniel W; GOUT, Peter W; WANG, Yu-Zhuo et al.The Prostate. 2007, Vol 67, Num 2, pp 162-171, issn 0270-4137, 10 p.Article

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor lineYUWEI WANG; HUI XUE; GOUT, Peter W et al.Laboratory investigation. 2005, Vol 85, Num 11, pp 1392-1404, issn 0023-6837, 13 p.Article

Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostinBAKHTYAR, Nazihah; WONG, Nicholas; KAPOOR, Anil et al.European journal of cancer (1990). 2013, Vol 49, Num 16, pp 3537-3546, issn 0959-8049, 10 p.Article

Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21ZHU, Chang-Qi; DA CUNHA SANTOS, Gilda; KAMEL-REID, Suzanne et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4268-4275, issn 0732-183X, 8 p.Article